The “LDL profile” factor was associated with a lower risk of death during 6 months after ALS diagnosis, while the “albumin & CRP” factor was associated with a lower risk of death during 1 year or 3 years after ALS diagnosis (Table 2). This evidence concerns the gene CRP and amyotrophic lateral sclerosis.